Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Evidence of Things Not Seen: The Match, Vienna & Unknown Unknowns

Philip Seo, MD, MHS  |  Issue: August 2022  |  August 13, 2022

The story of hepatitis C is a classic example of a diagnosis of exclusion. A serologic test to identify hepatitis B from blood donors was developed in 1974. A serologic test to identify hepatitis A was available a decade later. Screening the blood supply for these viruses, however, eliminated only about half of the post-transfusion cases of hepatitis. Because the evidence indicated the remaining cases were caused by a third virus, it was dubbed non-A, non-B hepatitis. It wasn’t until 1989 that scientists at the biotechnology company Chiron identified the culprit, which is now known as hepatitis C.12 For decades, this disease was a diagnosis of exclusion, until the diagnostic tests caught up.

Anyone can read a coronary calcium score off of a printout to diagnose a patient with atherosclerosis. Only a true clinician can diagnose a patient with … a rheumatic disease for which the perfect diagnostic tests do not yet exist.

U.S. Secretary of Defense Donald Rumsfeld stated, “As we know, there are known knowns; there are things we know we know. We also know there are known unknowns; that is to say, we know there are some things we do not know. But there are also unknown unknowns—the ones we don’t know we don’t know. And if one looks throughout history …, it is the latter category that tends to be the difficult one.”13

He might as well have been talking about rheumatology. The unknown unknowns represent the outer edge of our knowledge. We have a good sense of what remains unknown in rheumatology. The unknown unknowns represent the aspects of medicine we only think we understand—the chapters in the textbooks that are destined to be heavily rewritten. It’s the unknown unknowns that drive us to drag our puzzling patients back to the clinic so we can re-examine them, even after they have been given a putative diagnosis. These are precisely the patients who are routinely failed by diagnostic tests.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The diagnosis of exclusion has become in extricably linked with rheumatology because our diagnostic tests are so lacking. Only in rheumatology are we allowed to ignore antibody tests that don’t seem to speak to the patient’s diagnosis or to make diagnoses even when the supportive tests have refused to cooperate. Anyone can read a coronary calcium score off of a printout to diagnose a patient with atherosclerosis. Only a true clinician can diagnose a patient with adult-onset Still’s disease, seronegative rheumatoid arthritis or any one of a number of rheumatic diagnoses for which the perfect diagnostic tests do not yet exist.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:OpinionRheuminationsSpeak Out Rheum Tagged with:DiagnosisexclusionMatchresidency

Related Articles
    Corona Borealis Studio / shutterstock.com

    The Reliability & Utility of Serological Antibody Tests in COVID-19

    September 11, 2020

    Serological testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies may play a critical role in the management of the worldwide health crisis. Such testing may reveal key information for epidemiology, convalescent plasma therapies and vaccine development. However, the situation is complex, and much is unknown. Although such testing may ultimately be used to…

    Serological Antibody Tests in COVID-19: Test Reliability and Utility

    June 10, 2020

    Serological testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies may play a critical role in the management of the worldwide health crisis. Such testing may reveal key information for epidemiology, convalescent plasma therapies and vaccine development. However, the situation is complex, and much is unknown. Although such testing may ultimately be used to…

    A Live Patient Experience in Medical School Can Boost Interest in, and Knowledge of, Rheumatology

    July 9, 2023

    After intense academic classroom studies, University of Nebraska College of Medicine students in Omaha are able to put what they are learning in practice through the university’s Live Patient Experience (LPE) program, led by the Division of Rheumatology and Immunology. The LPE gives students real-life experience with patients and can serve as motivation to consider…

    Antiphospholipid Antibody Testing Update

    January 13, 2012

    Successes, challenges, and controversies of diagnostic methods for APS

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences